# FDA 483 - Samer Nakhle, M.D. - June 30, 2017

Source: https://www.keypedia.com/records/483/samer-nakhle-md/2187d1f2-43f7-4e76-96b9-6deb0e6b690a

> FDA 483 for Samer Nakhle, M.D. on June 30, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Samer Nakhle, M.D.
- Inspection Date: 2017-06-30
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Samer Nakhle, M.D. in Las Vegas, NV, a medical research center, identified a significant issue related to the conduct of an investigation. The firm failed to adhere to the investigational plan, specifically regarding subject inclusion criteria. This led to serious consequences, including a subject becoming pregnant and electing to terminate the pregnancy.

## Related Documents

- [483 - 2017-06-30](https://www.keypedia.com/records/483/samer-nakhle-md/bb4688f4-276d-4768-a6d5-b83271c2c29b)

## Related Officers

- [investigator](https://www.keypedia.com/people/humberto-z-gomez/6de682f6-ae2a-45ff-92ab-ba6ac7bb97b4)

Company: https://www.keypedia.com/companies/samer-nakhle-md/8939cfe3-6e8a-447d-a8fc-757e3cc18bf5

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b